Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
about
A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J MiceMetabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patientsReduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitisInhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxidesA protective lipidomic biosignature associated with a balanced omega-6/omega-3 ratio in fat-1 transgenic miceHyperinsulinemia shifted energy supply from glucose to ketone bodies in early nonalcoholic steatohepatitis from high-fat high-sucrose diet induced Bama minipigsNovel hepatic microRNAs upregulated in human nonalcoholic fatty liver diseaseMechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different gradesThe LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulationFatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque.Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.Induction of the hepatic stearoyl-CoA desaturase 1 gene in offspring after isocaloric administration of high fat sucrose diet during gestation.LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic HepatitisResolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseasesTranscriptional regulation of apolipoprotein A-IV by the transcription factor CREBHOmega-3 polyunsaturated fatty acids as an angelus custos to rescue patients from NSAID-induced gastroduodenal damage.Pharmacotherapy for Nonalcoholic Fatty Liver Disease.Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease.Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.Alternative RNA Splicing in the Pathogenesis of Liver Disease.Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signalingActivation of hepatic stellate cell in Pten null liver injury model.Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders.Occupational exposures at a polyvinyl chloride production facility are associated with significant changes to the plasma metabolome.Changes in milk composition in obese rats consuming a high-fat diet.Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes.Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats
P2860
Q28553462-673375C1-3B8B-441B-BE32-017AB18F7282Q33594722-ED1ECBCC-513D-4600-9F29-80452D609092Q34243636-1CA24229-0E13-45E9-96EB-70FA2EAE53A9Q34985408-9320084D-5ED6-44B6-82A4-E2BF03B7611AQ35156337-59C8CD5C-4085-41A6-ADC5-B67C4EE7D00AQ36049336-24558BA0-9D97-410B-B415-24CCFCC1175EQ36597717-D6E26359-CA51-4A89-8368-75642562E6D2Q36764809-4BE2FC1B-B881-4892-A0E5-D07B20B3C6AFQ36783013-619FC2E7-15BB-4CCE-A36D-B569DC65D2ABQ37042588-06A36FF9-4C31-4348-BF43-730227163BA4Q37166770-AF52A017-70F1-4216-8890-1E47510D5898Q37281717-BF937172-CC9D-46D9-B286-31D51CA07EAAQ37345576-0521F7CC-5E06-46A0-8A8A-3BB7CEF7D5ECQ37627490-84549EAA-2FE0-46B4-A600-82C84A9616ADQ37716353-7BDB8DBD-4890-4268-AC6E-F1B1A4B365F0Q38314106-0E084998-E82B-4583-BE7E-AFD88DD9363AQ38588344-11022374-62E2-4954-AD4E-56724FAFFC49Q38606360-9A36BA2F-1D6E-416D-B9F7-3888B1CDBAF7Q38651646-0D3ACF7D-6189-4AC3-99CA-9E2CC969C984Q38845683-B1271DA4-427A-472F-B930-A6DCC1DDDD5BQ38959081-C9DC4CE0-6CE1-456E-86B8-EB5FBD7EDEEAQ39109576-65BF6BD9-9B61-4D29-8464-A5033AEA96C3Q39356501-934C5240-B7F8-4071-9AED-7BFC15DF5D71Q39416487-15C22E9B-ABB6-4997-B301-EEA32150F778Q41090217-DE10C9BB-ABEF-44E0-B94E-9ACC6B27633EQ41933634-BE8A19FD-CDB5-4C3B-A2CE-0FFFEE2544CBQ47107756-872064DE-3243-4598-B0EB-3B9F34D58850Q47118229-E79110E8-B154-41D5-A750-465F152A843BQ50956593-0D35057B-EF09-455E-A169-C1E844F66010Q55122063-483FA70E-5475-4892-9925-9060084CB173Q57492697-26A0A4E5-B5EA-420E-AECC-8A4FD9FF2C0E
P2860
Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@en
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@nl
type
label
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@en
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@nl
prefLabel
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@en
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@nl
P2093
P2860
P1433
P1476
Molecular interplay between Δ5 ...... non-alcoholic steatohepatitis.
@en
P2093
Ana González-Périz
Bibiana Rius
Cristina López-Vicario
Esther Titos
Eva Morán-Salvador
Jing X Kang
Juan José Lozano
Montserrat Cofán
Ramón Bataller
Verónica García-Alonso
P2860
P304
P356
10.1136/GUTJNL-2012-303179
P407
P577
2013-03-14T00:00:00Z